CatchMark Timber Trust, Inc.

CTT Pharma Corporate Updates

CTT Pharma Files a Patent Continuation with the U.S. Patent Office

CTT Pharma Corporate Updates

CTT Pharma Receives U.S. Patent Approval for Nicotine, Vitamins, and Caffeine Delivery Technology

CTT Pharma Receives SEC Approval

CTT Pharma Signs LOI with European Company

CTT Pharmaceutical Holdings, Inc. Files Form S-1 Registration Statement and Advances Equity Line of Credit and Scientific Development Milestones

CTT Pharma's CEO will issue a Letter to Shareholders

CTT Pharma Signs Contract for $3 Million Equity Line of Credit

Correios De Portugal: A Surprising Buy On E-Commerce Growth Despite Mail Delivery Drag

CTT - Correios De Portugal, S.A. (CTTPY) Q1 2024 Earnings Call Transcript

CTT - Correios De Portugal, S.A. (CTTPY) Q4 2023 Earnings Call Transcript

CTT - Correios De Portugal, S.A. (CTTPY) Q3 2023 Earnings Call Transcript

CTT - Correios De Portugal, S.A. (CTTPY) Q2 2023 Earnings Call Transcript

PotlatchDeltic Announces Tax Treatment for CatchMark's 2022 Dividend Distributions

CTT - Correios De Portugal, S.A. (CTTPY) Q3 2022 Earnings Call Transcript

CatchMark Timber Trust, Inc. Stockholders Approve Merger with PotlatchDeltic Corporation

CatchMark Timber Trust Announces Proxy Advisory Firms Glass Lewis and ISS Recommend Stockholders Vote "FOR" Proposed Merger of CatchMark with PotlatchDeltic Corporation

These dividend stocks can protect you as the Federal Reserve slows the economy

SHAREHOLDER INVESTIGATION NOTICE: Halper Sadeh LLP Investigates HMTV, CTT, ZEN